Live Breaking News & Updates on Wuxi Bio

Stay updated with breaking news from Wuxi bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

WuXi Bio Prescribes Share Buyback To Relieve Revenue Pain (undefined:WXXWY)

WuXi Bio Prescribes Share Buyback To Relieve Revenue Pain (undefined:WXXWY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , South Korea , South Korean , Chen Zhisheng , Samsung Biologics , Hong Kong Stock Exchange , Contract Research , Wuxi Biologics Cayman Inc , Manufacturing Organization , Wuxi Bio , Wuxi Apptec , October Chen , Hangzhou Tigermed ,

WuXi Bio Prescribes Share Buyback To Relieve Revenue Pain

Key Takeaways: After its shares plunged more than 30% in a week, WuXi Bio announced a buyback of 10% of its shares, saying the battered price did not reflect the company’s value or business prospects   The company blamed the weaker revenue outlook on a financing slowdown in the biopharma industry and regulatory delays in launching star ....

South Korea , Hong Kong , South Korean , Chen Zhisheng , Molly Wen , Samsung Biologics , Contract Research , Hong Kong Stock Exchange , Wuxi Biologics Cayman Inc , Manufacturing Organization , Wuxi Bio , Wuxi Apptec , October Chen , Asymchem Laboratories , Hangzhou Tigermed ,

WuXi Biologics Extends Drop to 30% as Weak Outlook Fuels Caution

WuXi Biologics Extends Drop to 30% as Weak Outlook Fuels Caution
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Wuxi Biologics Cayman Inc , Wuxi Biologics Cayman , Wuxi Bio ,

Wuxi Bio Selloff Extends as Analysts Cut Forecasts

By Ben Otto


A selloff of Wuxi Biologics shares deepened Tuesday, taking losses this week to 30% as analysts cut forecasts in the wake of lowered guidance from the Chinese contract drugmaker.. ....

Hong Kong , Ben Otto , Astrazeneca Covid , Wuxi Biologics , Wuxi Bio , Matthew Law , Dow Jones ,

Contract manufacturing giant WuXi's stock plummets as it warns of $400M revenue miss

Contract manufacturing giant WuXi's stock plummets as it warns of $400M revenue miss
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Wilfred Yuen , Merck Kga , Hong Kong Stock Exchange , Wuxi Biologics , Daiwa Capital Markets , Wall Street , Wuxi Bio , Wuxi Apptec , Initial Public Offering , Hong Kong Stock , Wuxi Vaccines , Wuxi Vaccine ,